ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
w_i_z_z_a
|
169 |
57K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
169
|
57K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Ann: 2023 Annual Report to shareholders
|
|
w_i_z_z_a
|
169 |
57K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
169
|
57K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Completion of enrolment in Neuren's Angelman P2 trial
|
|
w_i_z_z_a
|
48 |
27K |
10 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
48
|
27K
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
w_i_z_z_a
|
9.9K |
4.4M |
3 |
12/04/24 |
12/04/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
w_i_z_z_a
|
8.0K |
2.9M |
10 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
10
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
w_i_z_z_a
|
8.0K |
2.9M |
4 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
4
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
w_i_z_z_a
|
8.0K |
2.9M |
20 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
20
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
w_i_z_z_a
|
8.0K |
2.9M |
3 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
3
|
|
ASX - By Stock
|
BOT |
Re:
BOT - Anything but charting
|
|
w_i_z_z_a
|
8.0K |
2.9M |
3 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
8.0K
|
2.9M
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Neuren - where to from here ?
|
|
w_i_z_z_a
|
91 |
51K |
3 |
29/03/24 |
29/03/24 |
ASX - By Stock
|
91
|
51K
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Neuren - where to from here ?
|
|
w_i_z_z_a
|
91 |
51K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
91
|
51K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Neuren - where to from here ?
|
|
w_i_z_z_a
|
91 |
51K |
13 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
91
|
51K
|
13
|
|
Charts
|
NEU |
Re:
Positive Reports
|
|
w_i_z_z_a
|
41 |
17K |
8 |
23/02/24 |
23/02/24 |
Charts
|
41
|
17K
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
w_i_z_z_a
|
316 |
159K |
28 |
22/02/24 |
22/02/24 |
ASX - By Stock
|
316
|
159K
|
28
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Comment on research report
|
|
w_i_z_z_a
|
316 |
159K |
25 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
316
|
159K
|
25
|
|
ASX - By Stock
|
NEU |
Re:
PLEASE DONATE FOR MELLAN ! GoFundMe
|
|
w_i_z_z_a
|
91 |
30K |
1 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
91
|
30K
|
1
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
w_i_z_z_a
|
1.6K |
824K |
5 |
06/02/24 |
06/02/24 |
Charts
|
1.6K
|
824K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
PLEASE DONATE FOR MELLAN ! GoFundMe
|
|
w_i_z_z_a
|
91 |
30K |
0 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
91
|
30K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
PLEASE DONATE FOR MELLAN ! GoFundMe
|
|
w_i_z_z_a
|
91 |
30K |
1 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
91
|
30K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
PLEASE DONATE FOR MELLAN ! GoFundMe
|
|
w_i_z_z_a
|
91 |
30K |
2 |
04/02/24 |
04/02/24 |
ASX - By Stock
|
91
|
30K
|
2
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
w_i_z_z_a
|
1.6K |
824K |
9 |
27/01/24 |
27/01/24 |
Charts
|
1.6K
|
824K
|
9
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
w_i_z_z_a
|
200 |
55K |
4 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
200
|
55K
|
4
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Three ViV Patients Completed under Health Canada SAP
|
|
w_i_z_z_a
|
28 |
7.8K |
2 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
28
|
7.8K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
w_i_z_z_a
|
200 |
55K |
5 |
22/01/24 |
22/01/24 |
ASX - By Stock
|
200
|
55K
|
5
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
w_i_z_z_a
|
1.6K |
824K |
0 |
22/01/24 |
22/01/24 |
Charts
|
1.6K
|
824K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Potential Takeover
|
|
w_i_z_z_a
|
121 |
52K |
1 |
15/01/24 |
15/01/24 |
ASX - By Stock
|
121
|
52K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
The NDD box seat
|
|
w_i_z_z_a
|
13 |
9.1K |
27 |
14/01/24 |
14/01/24 |
ASX - By Stock
|
13
|
9.1K
|
27
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
w_i_z_z_a
|
200 |
55K |
1 |
11/01/24 |
11/01/24 |
ASX - By Stock
|
200
|
55K
|
1
|
|
ASX - By Stock
|
AVR |
Re:
all will be revealed.
|
|
w_i_z_z_a
|
5 |
3.6K |
0 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
5
|
3.6K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
w_i_z_z_a
|
200 |
55K |
0 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
200
|
55K
|
0
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
w_i_z_z_a
|
200 |
55K |
1 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
200
|
55K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Merck to acquire Prometheus in a US$ 10.8 b deal
|
|
w_i_z_z_a
|
107 |
62K |
6 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
107
|
62K
|
6
|
|
ASX - By Stock
|
AVR |
Re:
Further Update on Edwards
|
|
w_i_z_z_a
|
200 |
55K |
2 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
200
|
55K
|
2
|
|
ASX - By Stock
|
AVR |
Re:
Ann: Investor Presentation
|
|
w_i_z_z_a
|
66 |
20K |
2 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
66
|
20K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
w_i_z_z_a
|
9.9K |
4.4M |
8 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
8
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Completion of enrolment in Neuren's Angelman P2 trial
|
|
w_i_z_z_a
|
48 |
27K |
9 |
05/01/24 |
05/01/24 |
ASX - By Stock
|
48
|
27K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
w_i_z_z_a
|
9.9K |
4.4M |
6 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
9.9K
|
4.4M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Completion of enrolment in Neuren's Angelman P2 trial
|
|
w_i_z_z_a
|
48 |
27K |
17 |
04/01/24 |
04/01/24 |
ASX - By Stock
|
48
|
27K
|
17
|
|
ASX - By Stock
|
NEU |
Re:
ANAVEX MEETS ENDPOINTS PHASE2 RETT
|
|
w_i_z_z_a
|
166 |
75K |
11 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
166
|
75K
|
11
|
|
ASX - By Stock
|
NEU |
Re:
ANAVEX MEETS ENDPOINTS PHASE2 RETT
|
|
w_i_z_z_a
|
166 |
75K |
5 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
166
|
75K
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Market Capitalisation is a Better Valuation Metric Than Share Price
|
|
w_i_z_z_a
|
100 |
62K |
14 |
31/12/23 |
31/12/23 |
ASX - By Stock
|
100
|
62K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
w_i_z_z_a
|
9.9K |
4.4M |
5 |
28/12/23 |
28/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
5
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
w_i_z_z_a
|
9.9K |
4.4M |
10 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
10
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
w_i_z_z_a
|
9.9K |
4.4M |
6 |
27/12/23 |
27/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
6
|
|
ASX - By Stock
|
NEU |
Re:
Take Over Opportunity
|
|
w_i_z_z_a
|
42 |
20K |
1 |
23/12/23 |
23/12/23 |
ASX - By Stock
|
42
|
20K
|
1
|
|
ASX - By Stock
|
NEU |
Re:
Merck to acquire Prometheus in a US$ 10.8 b deal
|
|
w_i_z_z_a
|
107 |
62K |
4 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
107
|
62K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
w_i_z_z_a
|
946 |
470K |
9 |
21/12/23 |
21/12/23 |
ASX - By Stock
|
946
|
470K
|
9
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
w_i_z_z_a
|
9.9K |
4.4M |
7 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
7
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
w_i_z_z_a
|
9.9K |
4.4M |
3 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
3
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
w_i_z_z_a
|
9.9K |
4.4M |
4 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
9.9K
|
4.4M
|
4
|
|